X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
unfavorable prognosis (226) 226
humans (179) 179
oncology (158) 158
index medicus (126) 126
prognosis (95) 95
cancer (94) 94
male (87) 87
female (77) 77
middle aged (70) 70
aged (64) 64
factor 1-alpha (61) 61
overexpression (59) 59
unfavorable-prognosis carcinoma (56) 56
breast-cancer (51) 51
expression (49) 49
immunohistochemistry (49) 49
metastasis (47) 47
adult (42) 42
endothelial growth-factor (42) 42
hypoxia (41) 41
radiotherapy (40) 40
angiogenesis (39) 39
pathology (39) 39
radiation-therapy (39) 39
cell biology (38) 38
prostate cancer (37) 37
tumors (37) 37
neoplasm staging (36) 36
aged, 80 and over (35) 35
urology & nephrology (35) 35
medical prognosis (34) 34
survival (34) 34
carcinoma (32) 32
gene expression (32) 32
health aspects (32) 32
care and treatment (31) 31
research (31) 31
analysis (30) 30
animals (30) 30
gene expression regulation, neoplastic (30) 30
radical prostatectomy (30) 30
apoptosis (29) 29
cell line, tumor (29) 29
hif-1α (29) 29
definitive radiotherapy (28) 28
hypoxia-inducible factor-1-alpha (28) 28
gene-expression (27) 27
proteins (27) 27
up-regulation (27) 27
poor-prognosis (26) 26
genetic aspects (25) 25
hif-1 alpha (25) 25
prostatic neoplasms - pathology (25) 25
development and progression (24) 24
prostatic neoplasms - radiotherapy (24) 24
phase-iii trial (23) 23
progression (23) 23
prostatic neoplasms - drug therapy (23) 23
biomarkers, tumor - metabolism (22) 22
proliferation (22) 22
androgen antagonists - therapeutic use (21) 21
biochemistry & molecular biology (21) 21
survival rate (21) 21
antineoplastic agents, hormonal - therapeutic use (20) 20
hypoxia-inducible factor 1, alpha subunit - metabolism (20) 20
microrna (20) 20
risk factors (20) 20
vascular endothelial growth factor (20) 20
cell proliferation (19) 19
lung cancer (19) 19
radiology, nuclear medicine & medical imaging (19) 19
squamous-cell carcinoma (19) 19
treatment outcome (19) 19
factor-1-alpha (18) 18
breast cancer (17) 17
cervical-cancer (17) 17
combined modality therapy (17) 17
epithelial-mesenchymal transition (17) 17
hypoxia-inducible factor 1, alpha subunit - genetics (17) 17
meta-analysis (17) 17
mice (17) 17
neoplasm invasiveness (17) 17
prostatic neoplasms - therapy (17) 17
survival analysis (17) 17
trial (17) 17
chemotherapy (16) 16
disease progression (16) 16
disease-free survival (16) 16
tumor angiogenesis (16) 16
androgen suppression (15) 15
chemotherapy, adjuvant (15) 15
diagnosis (15) 15
down-regulation (15) 15
e-cadherin (15) 15
factor-i (15) 15
follow-up studies (15) 15
gastric-cancer (15) 15
medicine & public health (15) 15
medicine, research & experimental (15) 15
neoplasms - metabolism (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Histology and Histopathology, ISSN 0213-3911, 04/2018, Volume 33, Issue 4, pp. 343 - 355
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide. Patients with HCC generally present at an advanced stage... 
Hepatocellular carcinoma | Biomarker | Prognosis | Expression | NONCODING RNA ANRIL | UNFAVORABLE PROGNOSIS | PROMOTES CELL-PROLIFERATION | DOWN-REGULATION | TRANSLOCATION GENE-1 | PATHOLOGY | CELL BIOLOGY | EPITHELIAL-MESENCHYMAL TRANSITION | TUMOR-SUPPRESSOR | PREDICTS POOR-PROGNOSIS | DECREASED EXPRESSION | CLINICAL-SIGNIFICANCE
Journal Article
Journal Article
Journal Article
Royal Society Open Science, ISSN 2054-5703, 12/2018, Volume 5, Issue 12, p. 181006
Journal Article
BMC Cancer, ISSN 1471-2407, 06/2010, Volume 10, Issue 1, pp. 307 - 307
Background: Hypoxia inducible factor 1 alpha (HIF-1 alpha) plays an essential role in the adaptive response of cells to hypoxia and is associated with... 
CELL LUNG-CANCER | BREAST-CANCER | OVEREXPRESSION | CYCLE INHIBITOR P27 | HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA | UNFAVORABLE PROGNOSIS | ANGIOGENIC PATHWAYS | ONCOLOGY | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | GENE-EXPRESSION | FREQUENT LOSS
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2005, Volume 11, Issue 3, pp. 1129 - 1135
Purpose: Renal cell carcinoma (RCC) is the most common malignancy of the kidney composed of specific tumor types. The sporadic conventional RCCs are, in... 
Western blot | renal cell carcinoma | hypoxia-inducible factor | HIF-1α | prognosis | FACTOR 1-ALPHA | OVEREXPRESSION | MESSENGER-RNA | UNFAVORABLE PROGNOSIS | ONCOLOGY | TUMOR-SUPPRESSOR GENE | HIF-1-ALPHA | HIF-ALPHA | CANCER | HIPPEL-LINDAU PROTEIN | ENDOTHELIAL GROWTH-FACTOR
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2006, Volume 12, Issue 23, pp. 6910 - 6919
Purpose: Metastasis is commonly associated with poor prognosis of hepatocellular carcinoma (HCC). Being an important angiogenic factor, vascular endothelial... 
HCC | HIF-1α | Id-1 | VEGF | LOOP-HELIX PROTEIN | OVEREXPRESSION | ACTIVATION | UNFAVORABLE PROGNOSIS | ONCOLOGY | TRANSCRIPTION | OVER-EXPRESSION | MICROVESSEL DENSITY | CELL-PROLIFERATION | CANCER | INTERLEUKIN-8
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2007, Volume 13, Issue 9, pp. 2568 - 2576
Purpose: Human papillomavirus (HPV)-16 oncoproteins, E6 and E7, are associated with enhanced tumor angiogenesis in human cervical cancers. The purpose of this... 
DNA tumor viruses | HPV oncoprotein | VEGF | angiogenesis | Cellular, Molecular, and Tumor Biology | HIF-1α | Angiogenic factors and receptors | Gynecologic cancers: cervical | human cervical cancer | FACTOR 1-ALPHA | UNFAVORABLE PROGNOSIS | ONCOLOGY | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | GENE-EXPRESSION | FACTOR-I | TUMOR ANGIOGENESIS | FACTOR RECEPTOR | FORESKIN KERATINOCYTES | RADICAL RADIOTHERAPY | RADIATION-THERAPY | Hypoxia-Inducible Factor 1, alpha Subunit - analysis | RNA, Small Interfering - genetics | Vascular Endothelial Growth Factor A | Humans | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Transcriptional Activation | Hypoxia-Inducible Factor 1, alpha Subunit - antagonists & inhibitors | Papillomavirus E7 Proteins | Stilbenes - pharmacology | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Transfection | Uterine Cervical Neoplasms - metabolism | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Female | Oncogene Proteins, Viral - genetics | Flavonoids - pharmacology | Chromones - pharmacology | Anticarcinogenic Agents - pharmacology | Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors | RNA, Small Interfering - pharmacology | Morpholines - pharmacology | Repressor Proteins - genetics | Uterine Cervical Neoplasms - genetics | Carcinoma - genetics | Neovascularization, Pathologic - genetics | Neovascularization, Pathologic - metabolism | Carcinoma - metabolism | HeLa Cells
Journal Article
Carcinogenesis, ISSN 0143-3334, 09/2012, Volume 33, Issue 9, pp. 1717 - 1725
Journal Article
BJU International, ISSN 1464-4096, 02/2008, Volume 101, Issue 4, pp. 480 - 484
Journal Article
Journal Article